Pharmaceutical Marketing

It's been almost 15 years since U.S. direct-to-consumer advertising regulations were loosened. And in those years, the consumer pharmaceutical marketing industry has gone from about $700 million in ad spending to a peak of $5.4 billion in 2006. Spending in 2010, about $4.3 billion, was down, but pharmaceutical advertising remains big business. This free white paper, produced with partner Kantar Media, examines the state of pharma marketing today, how digital information and social-media channels are changing the landscape, the still-evolving regulatory enivronment, the maturing of blockbuster drugs and the opportunities all of that brings.